Compound Detail
CHEMBL1234720
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1234720 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NMTNUQBORQILRK-XCVPVQRUSA-N |
2
Targets
5
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
214.2
MW (Da)
0.73
ALogP
3
HBA
2
HBD
83.8
PSA (Ų)
0.71
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 7.3
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 50.0 | nM | 7.3 | Inhibition of bovine brain PP2A assessed as dephosphorylation of substrate using... | 33454654 |
| Unchecked | IC50 | = | 560.0 | nM | 6.25 | Inhibition of PP1 (unknown origin) | 33454654 |
| KB 3-1 | IC50 | = | 79200.0 | nM | 4.1 | Anticancer activity against human KB 3-1 cells assessed as cell growth inhibitio... | 33454654 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33454654 | 10.1016/j.bmc.2021.116012 | Unchecked | 5 |
| 33454654 | 10.1016/j.bmc.2021.116012 | ADMET | 1 |
| 33454654 | 10.1016/j.bmc.2021.116012 | HepG2 | 1 |
| 33454654 | 10.1016/j.bmc.2021.116012 | HL-60 | 1 |
| 33454654 | 10.1016/j.bmc.2021.116012 | KB 3-1 | 1 |
| 33454654 | 10.1016/j.bmc.2021.116012 | Homo sapiens | 1 |
Data from ChEMBL 36 via Core Engine